Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
664.00    -15.00 (-2.21%)
Bid:
669.00
Ask:
671.00
Spread: 2.00 (0.299%)
Market Cap: £638.28m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Director/PDMR Shareholding

18 Apr 2019 11:57

RNS Number : 6551W
discoverIE Group plc
18 April 2019
 

18 April 2019

discoverIE Group plc

Director/PDMR Shareholding

 

discoverIE Group plc (LSE : DSCV, "discoverIE" or the "Company"), a leading international designer, manufacturer and supplier of customised electronics was notified of the following transactions in ordinary shares of 5 pence each in the Company ("Ordinary Shares") by Directors of the Company. 

Certain Directors have been issued new Ordinary Shares pursuant to the placing announced on 16 April 2019 as set out below. The new Ordinary Shares were issued to Directors on the same terms as other placees, at the placing price of 400 pence per share.

 

Name

Ordinary shares acquired pursuant

to placing

Total holding

following admission on 18 April 2019

Percentage held

of enlarged issued share capital

Simon Gibbins

5,000

262,670

0.33

Malcolm Diamond

5,000

24,907

0.03

Bruce Thompson

8,000

16,000

0.02

 

For further information, please contact:

Instinctif 0207 457 2020

Mark Garraway

James Gray

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Simon Gibbins

2

Reason for the notification

a)

Position / status

Group Finance Director

b)

Initial notification / amendment

Initial notification

3

Details of issuer

a)

Name

discoverIE Group plc

b)

LEI

213800BMDLQU1VEEAN68

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares in discoverIE Group plc

 

 

GB0000055888

b)

Nature of the transaction

Acquisition of shares pursuant to the placing of new Ordinary Shares

c)

Price(s) and volume(s)

 

Price

Volume

400 pence per share

5,000

 

 

d)

Aggregated information

 

Price

Volume

Total

400 pence per share

5,000

£20,000.00

e)

Date of the transaction

16 April 2019

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Malcolm Diamond

2

Reason for the notification

a)

Position / status

Non-Executive Chairman

b)

Initial notification / amendment

Initial notification

3

Details of issuer

a)

Name

discoverIE Group plc

b)

LEI

213800BMDLQU1VEEAN68

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares in discoverIE Group plc

 

 

GB0000055888

b)

Nature of the transaction

Acquisition of shares pursuant to the placing of new Ordinary Shares

c)

Price(s) and volume(s)

 

Price

Volume

400 pence per share

5,000

 

 

d)

Aggregated information

 

Price

Volume

Total

400 pence per share

5,000

£20,000

e)

Date of the transaction

16 April 2019

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Bruce Thompson

2

Reason for the notification

a)

Position / status

Non-executive Director

b)

Initial notification / amendment

Initial notification

3

Details of issuer

a)

Name

discoverIE Group plc

b)

LEI

213800BMDLQU1VEEAN68

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares in discoverIE Group plc

 

 

GB0000055888

b)

Nature of the transaction

Acquisition of shares pursuant to the placing of new Ordinary Shares

c)

Price(s) and volume(s)

 

Price

Volume

400 pence per share

8,000

d)

Aggregated information

 

 

Price

Volume

Total

400 pence per share

8,000

£32,000.00

e)

Date of the transaction

16 April 2019

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBGGDSUUBBGCI
Date   Source Headline
15th Sep 20239:11 amRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSAcquisition of 2J Antennas Group
5th Sep 20232:17 pmRNSNotification of Major Holdings
31st Aug 20237:00 amRNSAcquisition completion - Silvertel
1st Aug 20237:00 amRNSAcquisition of Silvertel
24th Jul 20232:31 pmRNSResults of Annual General Meeting
24th Jul 20237:00 amRNSTrading Update
27th Jun 202310:53 amRNSDirector / PDMR Shareholding
27th Jun 202310:47 amRNSNotification of Major Holdings
22nd Jun 202312:35 pmRNSAnnual Report & Notice of AGM
19th Jun 20238:35 amRNSNotification of Major Holdings
15th Jun 20239:51 amRNSDirector LTIP Award
7th Jun 20237:00 amRNSPreliminary results
1st Jun 20232:50 pmRNSNotification of Major Holdings
30th May 20237:00 amRNSAppointment of Non-Executive Director
18th May 20231:33 pmRNSNotification of Major Holdings
17th May 202310:25 amRNSNotice of Full Year Results
19th Apr 20237:00 amRNSFull Year Trading Update
18th Apr 20237:00 amRNSNotification of Major Holdings
29th Mar 20235:47 pmRNSNotification of Major Holdings
15th Mar 20233:53 pmRNSNotification of Major Holdings
15th Mar 20238:37 amRNSNotification of Major Holdings
15th Mar 20237:00 amRNSNotification of Major Holdings
23rd Feb 20232:58 pmRNSNotification of Major Holdings
20th Feb 20239:48 amRNSNotification of Major Holdings
15th Feb 20235:33 pmRNSNotification of Major Holdings
13th Feb 202311:36 amRNSNotification of Major Holdings
25th Jan 20237:00 amRNSQ3 Trading Update and Acquisition Completion
6th Jan 20231:41 pmRNSNotification of Major Holdings
6th Jan 20238:24 amRNSNotification of Major Holdings
3rd Jan 202310:38 amRNSNotification of Major Holdings
22nd Dec 20227:00 amRNSAcquisition of Magnasphere Corporation
14th Dec 20224:31 pmEQSParadigm Biopharmaceuticals (PAR): Adapted therapies to meet unmet demand
5th Dec 20229:53 amEQSdiscoverIE Group (DSCV): Focused on sustainable growth
2nd Dec 202212:58 pmRNSNotification of Major Holdings
2nd Dec 20228:37 amRNSNotification of Major Holdings
23rd Nov 202212:01 pmEQSdiscoverIE Group profits jump in 'very strong first half'
23rd Nov 20227:00 amRNSdiscoverIE Commits to Net Zero Emissions
23rd Nov 20227:00 amRNSInterim Results
21st Nov 20223:38 pmRNSNotification of Major Holdings
16th Nov 20228:58 amRNSTR-1: Notification of Major Holdings
14th Nov 20223:41 pmRNSIssue of Equity & Total Voting Rights
1st Nov 202212:08 pmRNSNotice of Half Year Results
1st Nov 20227:00 amRNSDirectorate Changes
14th Oct 20224:56 pmRNSNotification of Major Holdings
13th Oct 20223:31 pmRNSTR-1: Notification of major holdings
13th Oct 20227:00 amRNSFirst Half Trading Update
11th Oct 202211:42 amRNSNotification of Major Holdings
5th Oct 20227:52 amRNSNotification of Major Holdings
5th Oct 20227:52 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.